169 related articles for article (PubMed ID: 27664384)
1. Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers.
Ruscitti P; Cipriani P; Ciccia F; Masedu F; Liakouli V; Carubbi F; Berardicurti O; Guggino G; Di Benedetto P; Di Bartolomeo S; Valenti M; Triolo G; Giacomelli R
Autoimmun Rev; 2017 Jan; 16(1):16-21. PubMed ID: 27664384
[TBL] [Abstract][Full Text] [Related]
2. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients.
Ruscitti P; Rago C; Breda L; Cipriani P; Liakouli V; Berardicurti O; Carubbi F; Di Battista C; Verrotti A; Giacomelli R
Clin Rheumatol; 2017 Dec; 36(12):2839-2845. PubMed ID: 28914368
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
4. Application of the 2016 EULAR/ACR/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease.
Ahn SS; Yoo BW; Jung SM; Lee SW; Park YB; Song JJ
J Rheumatol; 2017 Jul; 44(7):996-1003. PubMed ID: 28412707
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort.
Ruscitti P; Iacono D; Ciccia F; Emmi G; Cipriani P; Grembiale RD; Perosa F; Emmi L; Triolo G; Giacomelli R; Valentini G
J Rheumatol; 2018 Jun; 45(6):864-872. PubMed ID: 29657144
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of macrophage activation syndrome in adult rheumatic disease: A multicenter retrospective study.
Ke Y; Lv C; Xuan W; Wu J; Da Z; Wei H; Zhang M; Tan W
Int J Rheum Dis; 2020 Nov; 23(11):1488-1496. PubMed ID: 32885598
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
Gilboa M; Bornstein G; Ben-Zvi I; Grossman C
Rheumatol Int; 2020 Apr; 40(4):663-669. PubMed ID: 31367795
[TBL] [Abstract][Full Text] [Related]
8. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases.
Lin CI; Yu HH; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
Clin Rheumatol; 2012 Aug; 31(8):1223-30. PubMed ID: 22615046
[TBL] [Abstract][Full Text] [Related]
9. [Macrophage activation syndrome: report on three cases].
Zietkiewicz M; Hajduk A; Wojteczek A; Smoleńska Z; Czuszyńska Z; Zdrojewski Z
Ann Acad Med Stetin; 2012; 58(1):55-61. PubMed ID: 23547396
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analysis.
Chen Y; Hu Z; Cai S; Shen G; Zhong J; Dong L
Semin Arthritis Rheum; 2022 Aug; 55():152043. PubMed ID: 35696776
[TBL] [Abstract][Full Text] [Related]
11. Expanding the spectrum of the hyperferritinemic syndrome, from pathogenic mechanisms to clinical observations, and therapeutic implications.
Ruscitti P; Di Cola I; Di Muzio C; Italiano N; Ursini F; Giacomelli R; Cipriani P
Autoimmun Rev; 2022 Jul; 21(7):103114. PubMed ID: 35595050
[TBL] [Abstract][Full Text] [Related]
12. Macrophage activation syndrome in autoimmune disease.
Deane S; Selmi C; Teuber SS; Gershwin ME
Int Arch Allergy Immunol; 2010; 153(2):109-20. PubMed ID: 20407267
[TBL] [Abstract][Full Text] [Related]
13. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients.
Minoia F; Davì S; Horne A; Demirkaya E; Bovis F; Li C; Lehmberg K; Weitzman S; Insalaco A; Wouters C; Shenoi S; Espada G; Ozen S; Anton J; Khubchandani R; Russo R; Pal P; Kasapcopur O; Miettunen P; Maritsi D; Merino R; Shakoory B; Alessio M; Chasnyk V; Sanner H; Gao YJ; Huasong Z; Kitoh T; Avcin T; Fischbach M; Frosch M; Grom A; Huber A; Jelusic M; Sawhney S; Uziel Y; Ruperto N; Martini A; Cron RQ; Ravelli A; ; ; ;
Arthritis Rheumatol; 2014 Nov; 66(11):3160-9. PubMed ID: 25077692
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
[TBL] [Abstract][Full Text] [Related]
15. [Macrophage activation syndrome].
Lehmann P; Huber E; Dörner T; Fleck M
Z Rheumatol; 2012 Oct; 71(8):701-6. PubMed ID: 22836385
[TBL] [Abstract][Full Text] [Related]
16. Secondary macrophage activation syndrome due to autoimmune, hematologic, infectious and oncologic diseases. Thirteen case series and review of the literature.
Egües Dubuc C; Aldasoro Cáceres V; Uriarte Ecenarro M; Errazquin Aguirre N; Hernando Rubio I; Meneses Villalba CF; Uriarte Itzazelaia E; Cancio Fanlo JJ; Maiz Alonso O; Belzunegui Otano JM
Reumatol Clin; 2015; 11(3):139-43. PubMed ID: 25441495
[TBL] [Abstract][Full Text] [Related]
17. New Onset Autoimmune Disease or Macrophage Activation Syndrome?
Greene JP; Wild BM
Pediatr Ann; 2019 Oct; 48(10):e395-e399. PubMed ID: 31609998
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of macrophage activation syndrome in the adult northern Chinese population.
Li X; Qu B; Nie Y; Zhu G; Li W; Mu F
Lupus; 2014 Jul; 23(8):785-92. PubMed ID: 24682586
[TBL] [Abstract][Full Text] [Related]
19. Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome.
Kobayashi M; Takahashi Y; Yamashita H; Kaneko H; Mimori A
Mod Rheumatol; 2011 Feb; 21(1):92-6. PubMed ID: 20737186
[TBL] [Abstract][Full Text] [Related]
20. Macrophage activation syndrome in adults: Characteristics, outcomes, and therapeutic effectiveness of etoposide-based regimen.
He L; Yao S; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
Front Immunol; 2022; 13():955523. PubMed ID: 36189240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
